PET tracers visualize α-synuclein, improving Parkinson's diagnosis

Researchers have made significant progress in developing positron emission tomography (PET) tracers to visualize α-synuclein protein aggregates, potentially enabling earlier Parkinson's disease diagnosis. These new PET tracers, like [18F]C05-05 and [18F]ACI-12589, have shown promise in distinguishing patients with synucleinopathies from healthy individuals and differentiating between different neurodegenerative diseases. This advancement allows for in-vivo imaging of the protein aggregates. This research could lead to improved early diagnosis, monitoring of disease progression, and evaluation of treatment responses for Parkinson's and related disorders, impacting clinical management and research.